flowjo—version 10.8.1 software (Becton Dickinson)
90
Structured Review
Becton Dickinson
flowjo—version 10.8.1 software
Flowjo—Version 10.8.1 Software, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flowjo+version+10+data+analysis+software/flowjo+version+10+8+1+software/pm36239557-106-6-8
Average 90 stars, based on 1 article reviews
Flowjo—Version 10.8.1 Software, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flowjo+version+10+data+analysis+software/flowjo+version+10+8+1+software/pm36239557-106-6-8
Average 90 stars, based on 1 article reviews
flowjo—version 10.8.1 software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Heterochiral dipeptide d-phenylalanyl- l-phenylalanine (H- D Phe- L Phe-OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild-type and mutant cells. Article Snippet: Funding information Council of Scientific and Industrial Research, India Abstract In recent years, significant progress has been made to the use‐case of small peptides because of their diversified edifice and hence their versatile application scope in cancer therapy.. Here we identify the heterochiral dipeptide H‐Phe‐Phe‐OH (F1) as a potent inducer of the metastatic suppressor NM23H1.. We divulge the effect of F1 on the major EMT/metastasis‐associated genes and the implications on the invasion and migration ability of cancer cells. Cytometry:Article Title: Heterochiral dipeptide d-phenylalanyl- l-phenylalanine (H- D Phe- L Phe-OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild-type and mutant cells. Article Snippet: Funding information Council of Scientific and Industrial Research, India Abstract In recent years, significant progress has been made to the use‐case of small peptides because of their diversified edifice and hence their versatile application scope in cancer therapy.. Here we identify the heterochiral dipeptide H‐Phe‐Phe‐OH (F1) as a potent inducer of the metastatic suppressor NM23H1.. We divulge the effect of F1 on the major EMT/metastasis‐associated genes and the implications on the invasion and migration ability of cancer cells. |